X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M | 2024-03-22 | TRDA | Kim Peter S | Dir | P - Purchase | $13.58 | +9,048 | 58,824 | +18% | +$122,882 | |||||
M | 2024-03-19 | TRDA | Kim Peter S | Dir | P - Purchase | $12.81 | +2,732 | 49,776 | +6% | +$34,996 | |||||
2024-03-06 | TRDA | Wentworth Kory James | CFO | S - Sale | $12.31 | -4,086 | 74,170 | -5% | -$50,285 | ||||||
2024-03-06 | TRDA | Dowden Nathan J | Pres, COO | S - Sale | $12.32 | -1,826 | 137,204 | -1% | -$22,499 | ||||||
2024-02-15 | TRDA | Doshi Dipal | CEO | S - Sale | $15.00 | -1,000 | 243,279 | 0% | -$15,000 | ||||||
2024-01-16 | TRDA | Doshi Dipal | CEO | S - Sale | $15.99 | -1,000 | 244,279 | 0% | -$15,990 | ||||||
DM | 2023-12-21 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $15.59 | -12,500 | 49,571 | -20% | -$194,845 | |||||
2023-12-20 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $15.00 | -1,000 | 245,279 | 0% | -$15,000 | ||||||
2023-11-13 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $16.23 | -1,000 | 246,279 | 0% | -$16,230 | ||||||
2023-10-17 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $15.00 | -1,000 | 247,279 | 0% | -$15,000 | ||||||
2023-09-13 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $15.00 | -1,000 | 248,279 | 0% | -$15,000 | ||||||
D | 2023-09-06 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $13.48 | -950 | 49,571 | -2% | -$12,806 | |||||
D | 2023-09-06 | TRDA | Kreher Nerissa | Chief Medical Officer | S - Sale+OE | $13.48 | -892 | 40,037 | -2% | -$12,022 | |||||
D | 2023-09-06 | TRDA | Dowden Nathan J | COO | S - Sale+OE | $13.47 | -972 | 48,168 | -2% | -$13,089 | |||||
2023-08-14 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $15.67 | -1,000 | 201,069 | 0% | -$15,671 | ||||||
DM | 2023-08-02 | TRDA | Kreher Nerissa | Chief Medical Officer | S - Sale+OE | $14.76 | -26,710 | 27,130 | -50% | -$394,219 | |||||
DM | 2023-07-10 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $17.99 | -10,000 | 36,747 | -21% | -$179,862 | |||||
M | 2023-07-10 | TRDA | Dowden Nathan J | COO | S - Sale | $18.03 | -7,097 | 35,376 | -17% | -$127,938 | |||||
M | 2023-07-10 | TRDA | Sethuraman Natarajan | Chief Scientific Officer | S - Sale | $18.03 | -17,878 | 153,447 | -10% | -$322,389 | |||||
D | 2023-06-21 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $15.01 | -17,500 | 27,957 | -38% | -$262,648 | |||||
M | 2023-06-20 | TRDA | Dowden Nathan J | COO | S - Sale | $15.42 | -15,982 | 42,473 | -27% | -$246,403 | |||||
2023-04-27 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $13.71 | -2,000 | 202,069 | -1% | -$27,422 | ||||||
2023-04-17 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $18.01 | -2,092 | 204,069 | -1% | -$37,675 | ||||||
2023-04-17 | TRDA | Sethuraman Natarajan | Chief Scientific Officer | S - Sale | $18.00 | -3,961 | 171,325 | -2% | -$71,316 | ||||||
2023-03-27 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $14.72 | -2,000 | 255,811 | -1% | -$29,435 | ||||||
D | 2023-03-02 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $10.53 | -1,747 | 42,157 | -4% | -$18,389 | |||||
D | 2023-03-02 | TRDA | Kreher Nerissa | Chief Medical Officer | S - Sale+OE | $10.56 | -1,641 | 41,330 | -4% | -$17,336 | |||||
2023-02-28 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $12.00 | -2,000 | 161,835 | -1% | -$24,000 | ||||||
2023-01-27 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $12.00 | -2,000 | 163,835 | -1% | -$24,001 | ||||||
2023-01-09 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $15.02 | -2,410 | 165,835 | -1% | -$36,196 | ||||||
2022-12-30 | TRDA | Kreher Nerissa | Chief Medical Officer | S - Sale | $13.45 | -5,200 | 15,516 | -25% | -$69,932 | ||||||
M | 2022-12-27 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $15.02 | -14,590 | 168,245 | -8% | -$219,119 | |||||
D | 2022-12-08 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $18.95 | -4,550 | 16,509 | -22% | -$86,238 | |||||
DM | 2022-12-02 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $18.19 | -3,110 | 16,509 | -16% | -$56,559 | |||||
2022-11-28 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $13.91 | -2,000 | 182,835 | -1% | -$27,826 | ||||||
D | 2022-11-16 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $18.10 | -200 | 16,509 | -1% | -$3,620 | |||||
2022-10-31 | TRDA | Dowden Nathan J | COO | S - Sale | $24.05 | -2,100 | 45,283 | -4% | -$50,495 | ||||||
DM | 2022-10-25 | TRDA | Kreher Nerissa | Chief Medical Officer | S - Sale+OE | $21.27 | -13,000 | 20,716 | -39% | -$276,549 | |||||
2022-10-25 | TRDA | Dowden Nathan J | COO | S - Sale | $20.77 | -9,348 | 47,383 | -16% | -$194,191 | ||||||
M | 2022-10-25 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $20.80 | -14,061 | 184,835 | -7% | -$292,512 | |||||
M | 2022-10-20 | TRDA | Dowden Nathan J | COO | S - Sale | $18.66 | -6,080 | 56,731 | -10% | -$113,426 | |||||
M | 2022-10-20 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $18.64 | -5,939 | 198,896 | -3% | -$110,713 | |||||
M | 2022-09-26 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $15.25 | -10,587 | 204,835 | -5% | -$161,442 | |||||
DM | 2022-09-26 | TRDA | Kreher Nerissa | Chief Medical Officer | S - Sale+OE | $15.29 | -8,593 | 20,716 | -29% | -$131,428 | |||||
2022-09-26 | TRDA | Dowden Nathan J | COO | S - Sale | $15.45 | -1,544 | 62,811 | -2% | -$23,854 | ||||||
M | 2022-09-21 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $15.10 | -4,425 | 215,422 | -2% | -$66,838 | |||||
DM | 2022-09-21 | TRDA | Kreher Nerissa | Chief Medical Officer | S - Sale+OE | $15.08 | -4,280 | 20,716 | -17% | -$64,560 | |||||
M | 2022-09-21 | TRDA | Dowden Nathan J | COO | S - Sale | $15.11 | -4,293 | 64,355 | -6% | -$64,878 | |||||
2022-09-15 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $15.04 | -200 | 219,847 | 0% | -$3,008 | ||||||
2022-09-15 | TRDA | Dowden Nathan J | COO | S - Sale | $15.01 | -100 | 68,648 | 0% | -$1,501 | ||||||
D | 2022-09-15 | TRDA | Kreher Nerissa | Chief Medical Officer | S - Sale+OE | $15.01 | -106 | 20,716 | -1% | -$1,591 | |||||
M | 2022-09-08 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $15.12 | -1,788 | 220,047 | -1% | -$27,039 | |||||
DM | 2022-09-08 | TRDA | Kreher Nerissa | Chief Medical Officer | S - Sale+OE | $15.11 | -2,021 | 20,716 | -9% | -$30,531 | |||||
M | 2022-09-08 | TRDA | Dowden Nathan J | COO | S - Sale | $15.11 | -1,777 | 68,748 | -3% | -$26,845 | |||||
M | 2022-08-29 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $12.72 | -2,000 | 206,710 | -1% | -$25,435 | |||||
DM | 2022-08-24 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $13.78 | -4,669 | 10,986 | -30% | -$64,362 | |||||
DM | 2022-08-19 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $13.08 | -11,655 | 14,538 | -44% | -$152,432 | |||||
DM | 2022-08-16 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $13.02 | -600 | 20,221 | -3% | -$7,814 | |||||
2022-07-27 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $12.00 | -2,000 | 208,710 | -1% | -$24,000 | ||||||
2022-06-27 | TRDA | Dowden Nathan J | COO | S - Sale | $13.00 | -7,714 | 64,893 | -11% | -$100,282 | ||||||
2022-06-27 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $12.00 | -4,000 | 210,710 | -2% | -$48,000 | ||||||
M | 2022-06-02 | TRDA | Baker Bros. Advisors LP | 10% | P - Purchase | $6.37 | +40,947 | 4,501,658 | +1% | +$260,760 | |||||
M | 2022-05-20 | TRDA | Baker Bros. Advisors LP | 10% | P - Purchase | $5.82 | +48,509 | 4,465,029 | +1% | +$282,447 | |||||
M | 2022-05-16 | TRDA | Baker Bros. Advisors LP | 10% | P - Purchase | $5.99 | +71,944 | 4,421,689 | +2% | +$430,701 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |